Expressions of CD274, CTLA4, LAG3, PDCD1, PDCD1LG2, and SIGLEC15 were shown to be significantly different between normal and tumor samples in immune checkpoint analysis. This evidence concerns the gene SIGLEC15 and neoplasm.